# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-26-325031
Filing Date
2026-07-30
Accepted
2026-07-30 08:32:49
Documents
11
Period of Report
2026-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | iron-20260730.htm iXBRL | 8-K | 46251
2 | EX-99.1 | iron-ex99_1.htm | EX-99.1 | 164556
3 | GRAPHIC | img57926557_0.jpg | GRAPHIC | 896859
| Complete submission text file | 0001193125-26-325031.txt |  | 1539746

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | iron-20260730.xsd | EX-101.SCH | 26027
14 | EXTRACTED XBRL INSTANCE DOCUMENT | iron-20260730_htm.xml | XML | 4922

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 261220366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)